Tower Research Capital LLC (Trc) Lexicon Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,690 shares of LXRX stock, worth $13,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,690
Previous 28,107
54.85%
Holding current value
$13,451
Previous $12,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
32 transactions
Others Institutions Holding LXRX
# of Institutions
126Shares Held
225MCall Options Held
373KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$144 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$41.3 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$9.38 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$4.85 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $200M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...